Better Decisions Through Quantitative Science
For teams making high-stakes decisions
Who we are
DoseQuant is a quantitative pharmacology consultancy that translates complex biological and clinical data into clear, actionable decisions. We combine scientific expertise with quantitative modeling – including pharmacometrics, clinical trial design, and regulatory review – to support research and clinical programs and deliver safer, more effective therapies.
Capabilities
Model-Informed dose optimization
Data-driven dose selection and optimization grounded in PK/PD principles.
Quantitative analytics
Robust modeling and simulation to support critical decisions.
Research & clinical support
Pharmacometric advice, clinical trial design, and expert review.
Our Clients
DoseQuant supports teams who rely on quantitative evidence to guide critical choices across drug development and investment.
- Pharmaceutical and biotechnology companies
- Clinical researchers and trial teams
- Quantitative scientists and pharmacometricians
- Biotechnology Investors
Why DoseQuant?
Science-first approach
Decisions grounded in quantitative pharmacology and state-of-the-art
modeling.
Credibility
Methods and conclusions that
stand up to regulatory
and scientific scrutiny.
Decision-driven outputs
Analyses designed to inform real-
world decisions, not just
generate results.
Transparent workflow
Clear documentation of
assumptions, methods,
and interpretations.
Founder’s message: From data to decisions
DoseQuant was founded on a simple belief that rigorous quantitative science should directly inform real-world decisions. My goal is to help teams move from complex data to clear, confident action.
I am a Professor of Clinical Pharmacology and an internationally recognized expert in pharmacometrics and dose optimization, with 20 years of experience supporting drug development and clinical decisions. My work has focused in particular on anti-infective therapies and underserved populations. I have contributed to several World Health Organization (WHO) treatment guidelines, and my research includes more than 275 peer-reviewed publications (full list here). Through DoseQuant, I work with research and clinical teams to translate quantitative insight into practical, decision-ready guidance.
Prof. Joel Tarning, CEO & Founder
Interested in discussing a project or collaboration?
Get in touch to explore how DoseQuant can support your work.